XML 50 R38.htm IDEA: XBRL DOCUMENT
v3.25.3

FAIR VALUE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Fair Value Disclosures [Abstract] |
Schedule of Fair Values of Financial Assets And Liabilities | As of September 30, 2025, the fair values of our financial assets and liabilities were categorized as follows:
| Total |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |
Investment in equity securities (1) | $ | 3,831 |  |  | $ | 3,831 |  |  | $ | — |  |  | $ | — |
Foreign exchange contracts (2) | 113 |  |  | — |  |  | 113 |  |  | — |
Convertible notes (3) | 5,650 |  |  | — |  |  | — |  |  | 5,650 |
Total assets at fair value | $ | 9,594 |  |  | $ | 3,831 |  |  | $ | 113 |  |  | $ | 5,650 |
Liabilities |  |  |  |  |  |  |
Foreign exchange contracts (2) | $ | 892 |  |  | $ | — |  |  | $ | 892 |  |  | $ | — |
Cross currency swap contract (2) | 33,824 |  |  | — |  |  | 33,824 |  |  | — |
Total liabilities at fair value | $ | 34,716 |  |  | $ | — |  |  | $ | 34,716 |  |  | $ | — |
As of December 31, 2024, the fair values of our financial assets and liabilities were categorized as follows:
| Total |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |
Investment in equity securities (1) | $ | 2,986 |  |  | $ | 2,986 |  |  | $ | — |  |  | $ | — |
Foreign exchange contracts (2) | 572 |  |  | — |  |  | 572 |  |  | — |
Convertible note (3) | 5,650 |  |  | — |  |  | — |  |  | 5,650 |
Total assets at fair value | $ | 9,208 |  |  | $ | 2,986 |  |  | $ | 572 |  |  | $ | 5,650 |
Liabilities |  |  |  |  |  |  |
Foreign exchange contracts (2) | $ | 622 |  |  | $ | — |  |  | $ | 622 |  |  | $ | — |
Cross currency swap contract (2) | 11,851 |  |  | — |  |  | 11,851 |  |  | — |
Total liabilities at fair value | $ | 12,473 |  |  | $ | — |  |  | $ | 12,473 |  |  | $ | — |
________________________________________________ (1)Investment in PureCycle Technologies (“PCT” or “PureCycle”). See Note 18 – Investment in Equity Securities for discussion of this investment. (2)Market approach valuation technique based on observable market transactions of spot and forward rates. (3)Investment in convertible notes in Enable Injections, Inc. and Siklus Refill Pte, Ltd. The investments are included within Miscellaneous assets in our Condensed Consolidated Balance Sheets.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration